Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a public health emergency. Though originally described as a respiratory virus, SARS-CoV-2 has now been shown to have multiorgan involvement.1 Chronic kidney disease (CKD) has emerged as a risk factor for adverse outcomes. In this issue of AJKD, Ng et al2 and Flythe et al3 explore the association of the spectrum of kidney disease with outcomes in patients hospitalized with COVID-19.